Logotype for NewMed Energy - Limited Partnership

NewMed Energy (NWMD) Q4 2025 earnings summary

Event summary combining transcript, slides, and related documents.

Logotype for NewMed Energy - Limited Partnership

Q4 2025 earnings summary

20 May, 2026

Executive summary

  • Q1 2026 results were impacted by a 33-day shutdown of the Leviathan platform, resulting in significantly lower income, EBITDA, and net profit compared to Q1 2025.

  • Revenues for Q1 2026 were $164 million with production of 1.9 BCM, down from $288 million and 2.9 BCM in Q1 2025.

  • Net profit for Q1 2026 was $0.1 million, compared to $160 million in the prior year.

  • FY 2025 average sales reached 1,063 MMcf/d (187 Mboe/d), with Q4 at 1,093 MMcf/d (192 Mboe/d).

  • Leviathan Expansion FID achieved; 3rd Gathering Line completed with $90mm budget saving.

Financial highlights

  • FY 2025 sales: $1,094mm; EBITDA: $1,013mm; Net profit: $343mm.

  • Q4 2025 sales: $277mm; EBITDA: $191mm; Net profit: $120mm.

  • Q1 2026 revenues were $164 million, with a net profit of $0.1 million.

  • The 33-day shutdown reduced revenues by $76 million; lower gas prices cut revenues by $27 million.

  • One-time amortization of $74 million due to unsuccessful drilling in Bulgaria impacted expenses.

Outlook and guidance

  • Full-year 2026 revenues for Leviathan are now forecast at $288 million, up from $255 million previously assumed, based on $90 Brent price.

  • Upside of $330 million in income expected for 2026, with further upgrades possible after new pipeline projects come online.

  • Leviathan production capacity to increase from 14 bcm/y to 21 bcm/y after expansion.

  • Regional export capacity expected to reach 1,625 mmcf/d by 2028 with new pipeline projects.

  • Krum prospect drilling underway, with results expected soon.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more